Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2019-08-02

Original market date: See footnote 1

1988-12-31

Product name:

PANCREASE MT 10

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

00789437

Product Monograph/Veterinary Labelling:

Date: 2020-08-12 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

VIVUS INC.
900 East Hamilton Avenue, Suite 550
Campbell
California
United States  95008

Class: 

Human

Dosage form(s):

Capsule (Delayed Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

56:16.00   DIGESTANTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A09AA02  MULTIENZYMES (LIPASE, PROTEASE ETC)

Active ingredient group (AIG) number:See footnote 5

0302964029

List of active ingredient(s)
Active ingredient(s) Strength
AMYLASE 43750 UNIT
LIPASE 10500 UNIT
PROTEASE 25000 UNIT

Application information

Related information

Contact us

Version 3.9.1
Date modified: